top of page
Reproductive & Endocrine Systems
Pheochromocytoma
Core Principle of Pheochromocytoma
🧷
Pheochromocytomas are catecholamine-secreting tumors arising from chromaffin cells in the adrenal medulla, while extra-adrenal paragangliomas arise from sympathetic ganglia.
🧷
These tumors produce excessive epinephrine, norepinephrine, or both, leading to episodic or sustained hypertension and a constellation of hyperadrenergic symptoms.
🧷
The "10% rule" historically described pheochromocytomas: 10% bilateral, 10% extra-adrenal, 10% malignant, 10% familial, 10% in children — though modern data shows higher rates of hereditary cases (up to 40%).
🧷
Board pearl: Pheochromocytoma is a rare but critical "can't miss" diagnosis because undiagnosed tumors can cause hypertensive crisis during surgery, pregnancy, or with certain medications.

Catecholamine Synthesis and Metabolism Pathway
📍
Chromaffin cells synthesize catecholamines: Tyrosine → DOPA (via tyrosine hydroxylase) → Dopamine → Norepinephrine (via dopamine β-hydroxylase) → Epinephrine (via PNMT).
📍
Pheochromocytomas typically secrete norepinephrine > epinephrine, while normal adrenal medulla secretes mainly epinephrine.
📍
Catecholamines are metabolized to metanephrines (normetanephrine from norepinephrine, metanephrine from epinephrine) via COMT, then to VMA via MAO.
📍
Board pearl: Plasma free metanephrines or 24-hour urine fractionated metanephrines are the most sensitive screening tests because tumors continuously metabolize catecholamines intracellularly regardless of secretion.

Classic Clinical Presentation: The 5 P's
🔹
Paroxysms of symptoms, Pallor, Palpitations, Perspiration (profuse sweating), and Pressure (hypertension).
🔹
Episodes classically last 15-60 minutes and can be triggered by abdominal pressure, exercise, urination, defecation, anesthesia, or foods high in tyramine.
🔹
Between attacks, patients may be normotensive (especially early in disease) or have sustained hypertension.
🔹
Additional symptoms include headache (90% of symptomatic patients), anxiety, tremor, chest or abdominal pain, and weight loss despite normal appetite.
🔹
Board clue: The triad of episodic headache + sweating + palpitations in a hypertensive patient is highly specific for pheochromocytoma.

Hypertensive Crisis and Catecholamine Effects
⭐
α-receptor stimulation → vasoconstriction → severe hypertension, pallor, cool extremities.
⭐
β₁-receptor stimulation → increased heart rate, contractility → palpitations, arrhythmias.
⭐
β₂-receptor stimulation → tremor, anxiety, glycogenolysis → hyperglycemia.
⭐
Massive catecholamine release can cause catecholamine cardiomyopathy with acute heart failure, pulmonary edema, or takotsubo-like syndrome.
⭐
Board pearl: Pheochromocytoma can present with orthostatic hypotension despite catecholamine excess due to hypovolemia from pressure natriuresis and downregulated receptors.

Hereditary Syndromes and Genetic Associations
✅
MEN2A and MEN2B (RET mutations): pheochromocytomas are bilateral in 50-80% of cases.
✅
Von Hippel-Lindau (VHL mutations): pheochromocytomas + hemangioblastomas + clear cell RCC + pancreatic tumors.
✅
Neurofibromatosis type 1 (NF1 mutations): café-au-lait spots + neurofibromas + pheochromocytomas.
✅
Familial paraganglioma syndromes (SDH mutations): often extra-adrenal, higher malignancy risk.
✅
Board pearl: All patients diagnosed with pheochromocytoma should undergo genetic testing, as 40% have germline mutations even without family history.

Biochemical Diagnosis: Test Selection and Interpretation
🧠
First-line tests: plasma free metanephrines or 24-hour urine fractionated metanephrines (sensitivity >95%).
🧠
Plasma metanephrines: draw after 30 minutes supine rest; 3-4× upper limit of normal is diagnostic.
🧠
24-hour urine: collect during or immediately after symptomatic episode if possible; correct for creatinine.
🧠
False positives: tricyclic antidepressants, decongestants, antipsychotics, withdrawal from clonidine, severe stress.
🧠
Board distinction: Plasma catecholamines are less reliable due to episodic secretion and short half-life — metanephrines are superior.

Anatomic Localization and Imaging
⚡
After biochemical confirmation, localize tumor with CT or MRI of abdomen/pelvis (initial test).
⚡
Pheochromocytomas appear as well-circumscribed adrenal masses with avid contrast enhancement; may show cystic degeneration or hemorrhage.
⚡
MRI shows characteristic "lightbulb bright" T2 signal due to high water content.
⚡
If CT/MRI negative or metastatic disease suspected → ¹²³I-MIBG scan or ⁶⁸Ga-DOTATATE PET.
⚡
Board pearl: Never biopsy an adrenal mass without first excluding pheochromocytoma biochemically — biopsy can trigger hypertensive crisis.

Paragangliomas: Extra-Adrenal Tumors
📌
Arise from sympathetic ganglia along the paravertebral axis from skull base to pelvis.
📌
Common locations: organ of Zuckerkandl (aortic bifurcation), bladder, mediastinum, carotid body, glomus jugulare.
📌
Bladder paragangliomas present with micturition-induced hypertensive episodes and hematuria.
📌
Head/neck paragangliomas (carotid body, glomus tumors) are usually non-secretory but can cause mass effect.
📌
Board clue: Young patient with hypertensive episodes during urination → consider bladder paraganglioma.

Preoperative Medical Management
📣
α-blockade must precede β-blockade to prevent unopposed α-stimulation → hypertensive crisis.
📣
Start phenoxybenzamine (irreversible α-blocker) or doxazosin (selective α₁-blocker) 10-14 days before surgery.
📣
Add β-blocker only after adequate α-blockade established (blood pressure controlled, orthostatic symptoms).
📣
Liberal salt and fluid intake to expand plasma volume contracted by chronic vasoconstriction.
📣
Board pearl: Starting β-blocker before α-blocker in pheochromocytoma → paradoxical hypertension from unopposed α-receptor stimulation.

Surgical Approach and Intraoperative Management
🔸
Laparoscopic adrenalectomy is preferred for tumors <6 cm; open approach for larger or invasive tumors.
🔸
Anesthesia team must be prepared for hemodynamic swings: hypertension during tumor manipulation, hypotension after tumor vessel ligation.
🔸
Short-acting agents used intraoperatively: nitroprusside or nicardipine for hypertension, norepinephrine for hypotension.
🔸
Cortical-sparing adrenalectomy considered for bilateral disease to preserve adrenal function.
🔸
Board distinction: Post-resection hypotension results from sudden catecholamine withdrawal + residual α-blockade + hypovolemia.

Malignant Pheochromocytoma
🧷
No reliable histologic criteria distinguish benign from malignant — diagnosis requires metastases to non-chromaffin tissue.
🧷
Metastatic sites: bones, liver, lungs, lymph nodes (not direct invasion or lymph nodes within tumor).
🧷
Risk factors for malignancy: large size (>5 cm), extra-adrenal location, SDHB mutations.
🧷
¹²³I-MIBG therapy for metastatic disease; also chemotherapy (CVD regimen), radiation, or peptide receptor radionuclide therapy.
🧷
Board pearl: A pheochromocytoma is only diagnosed as malignant when metastases are found — cellular atypia alone is insufficient.

Special Clinical Scenarios
📍
Pregnancy: α-methyldopa is contraindicated (can worsen hypertension); use phenoxybenzamine; timing of surgery depends on gestational age.
📍
Hypertensive crisis: phentolamine IV (short-acting α-blocker), avoid pure β-blockers.
📍
Contrast administration: modern non-ionic contrast is generally safe with α-blockade, though historical teaching warned of crisis.
📍
Incidentaloma workup: all adrenal masses require pheochromocytoma exclusion before intervention.
📍
Board clue: Pregnant woman with paroxysmal hypertension unresponsive to standard therapy → screen for pheochromocytoma.

Post-Operative Follow-Up and Surveillance
🔹
Measure plasma or urine metanephrines 2-4 weeks post-operatively to confirm complete resection.
🔹
Annual biochemical testing lifelong due to risk of recurrence, contralateral disease, or metastases.
🔹
Genetic syndrome patients need screening for associated tumors and family cascade testing.
🔹
5-year survival >95% for benign disease, 40-70% for malignant disease depending on tumor burden.
🔹
Board pearl: Persistently elevated metanephrines post-operatively suggests residual disease, metastases, or second primary tumor.

Differential Diagnosis of Episodic Symptoms
⭐
Panic disorder: no biochemical abnormalities, responds to anxiolytics/SSRIs.
⭐
Hyperthyroidism: sustained symptoms, elevated thyroid hormones, suppressed TSH.
⭐
Carcinoid syndrome: flushing + diarrhea, elevated 5-HIAA, right heart involvement.
⭐
Mastocytosis: flushing + urticaria, elevated tryptase, triggered by physical stimuli.
⭐
Drug effects: cocaine, amphetamines, MAO inhibitor + tyramine, clonidine withdrawal.
⭐
Board distinction: Pheochromocytoma causes pallor during attacks (vasoconstriction), while carcinoid causes flushing (vasodilation).

Catecholamine Cardiomyopathy
✅
Chronic catecholamine excess → myocardial fibrosis, LV hypertrophy, dilated cardiomyopathy.
✅
Acute presentation: takotsubo-like syndrome with apical ballooning, pulmonary edema, cardiogenic shock.
✅
ECG shows LVH, strain pattern, arrhythmias; elevated troponin without coronary disease.
✅
Echo reveals global or segmental dysfunction that may reverse after tumor resection.
✅
Board pearl: Young patient with unexplained cardiomyopathy + hypertension → consider pheochromocytoma as reversible cause.

Drug Interactions and Perioperative Pitfalls
🧠
Metoclopramide, droperidol → dopamine receptor blockade → catecholamine release → crisis.
🧠
Glucagon stimulation test historically used but abandoned due to risk of massive catecholamine release.
🧠
Succinylcholine → fasciculations → abdominal pressure → tumor stimulation.
🧠
Morphine → histamine release → potential crisis (fentanyl preferred).
🧠
Board clue: Question about drugs to avoid in suspected pheochromocytoma → dopamine antagonists, histamine releasers, or direct tumor pressure.

Biochemical Patterns and Test Interpretation
⚡
Norepinephrine-secreting tumors: hypertension + pallor + ↑ normetanephrine.
⚡
Epinephrine-secreting tumors: palpitations + tremor + hyperglycemia + ↑ metanephrine.
⚡
Dopamine-secreting tumors: rare, often malignant, may have minimal symptoms, ↑ methoxytyramine.
⚡
VMA less sensitive than metanephrines; affected by dietary vanillin (chocolate, coffee, bananas).
⚡
Board pearl: Plasma metanephrines drawn sitting/standing or during stress → false positive; must be drawn supine after rest.

Imaging Pitfalls and Problem-Solving
📌
Adrenal adenomas can coexist with pheochromocytoma → biochemical testing essential.
📌
Bilateral adrenal masses in MEN2 → assume bilateral pheochromocytomas until proven otherwise.
📌
Negative imaging with positive biochemistry → consider paraganglioma, whole body imaging.
📌
¹²³I-MIBG uptake blocked by tricyclics, labetalol → false negative scan.
📌
Board distinction: CT shows enhancement >10 HU and delayed washout <50% suggests pheochromocytoma over adenoma.

Board Question Stem Patterns
📣
Episodic headache + sweating + palpitations → pheochromocytoma until proven otherwise.
📣
Hypertensive crisis during surgery/labor/colonoscopy → undiagnosed pheochromocytoma.
📣
Young patient + bilateral adrenal masses → MEN2 syndrome.
📣
Hypertension worsening with β-blocker → consider pheochromocytoma with unopposed α-stimulation.
📣
Post-operative hypoglycemia in adrenalectomy patient → loss of catecholamine-induced gluconeogenesis.
📣
Neurofibromas + hypertension → screen for pheochromocytoma.
📣
Elevated metanephrines + negative adrenal imaging → look for paraganglioma.

One-Line Recap
🔸
Pheochromocytoma is a catecholamine-secreting tumor presenting with episodic hypertension, headache, sweating, and palpitations, diagnosed by elevated plasma/urine metanephrines, localized by CT/MRI, treated with α-blockade before β-blockade then surgical resection, and associated with genetic syndromes in 40% of cases requiring lifelong surveillance.

bottom of page

